Dianthus Therapeutics Inc (NAS:DNTH)
$ 94.34 +4.13 (+4.58%) Market Cap: 5.16 Bil Enterprise Value: 4.05 Bil PE Ratio: 0 PB Ratio: 4.29 GF Score: 22/100

Dianthus Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 11:00 PM GMT
Release Date Price: $39.12 (+2.44%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DNTH.OQ - Dianthus Therapeutics Inc
Dianthus Therapeutics Inc at JPMorgan Healthcare Conference
Jan 12, 2026 / 11:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, everyone. I hope you're enjoying the first day of the conference and all the festivities. My name's Alex Buckley. I'm with the Healthcare Investment Banking Group, and it's my pleasure to introduce Dianthus Therapeutics, and Marino Garcia, CEO.

We'll have some time at the end for Q&A. If you could just raise your hand, and there'll be a mic that goes around with that, Marina.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Alex.

And thank you to JP Morgan for the opportunity to present today an update on
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot